However, oral administration of NK210 and/or NK219 decreased cognitive impairment-like behaviors and NF-κB+/Iba1+ cell population in the hippocampus, while BDNF+/NeuN+ cell population increased. This evidence concerns the gene RBFOX3 and Cognitive impairment.